Israeli diagnostics device manufacturer Itamar Medical has secured US Food and Drug Administration (FDA) 510(k) clearance for the disposable home sleep apnoea test (HSAT), WatchPAT One.

Based on the company’s WatchPAT technology, the test is designed for use in clinics and practices with limited resources, infrastructure or capital.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

WatchPAT One can be linked to the WatchPAT device via the company’s smartphone app. The test collects sleep study data, which is automatically transmitted to Itamar Medical’s CloudPAT server.

After the completion of the test, WatchPAT’s True Sleep Time, Sleep Architecture and Central Plus algorithms are used to automatically generate a comprehensive report and send to the prescribing physician.

Itamar Medical president and CEO Gilad Glick said: “We expect the availability of a disposable WatchPAT system will improve patient access by increasing the number of physicians able to offer our cutting-edge technology to their patients.

“Additionally, as a disposable HSAT, WatchPAT One may have particular utility in the inpatient setting, where transmission of infection through reusable medical devices is a significant concern.”

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The company focuses on research, development, sales and marketing of non-invasive medical devices to diagnose respiratory sleep disorders.

Its portfolio includes Total Sleep Solution, designed to enable comprehensive sleep apnoea management in different clinical settings to optimise patient care and minimise healthcare costs.

In addition, Itamar Medical offers a WatchPAT home-use diagnostic device for sleep breathing disorders.

“WatchPAT One may have particular utility in the inpatient setting, where transmission of infection through reusable medical devices is a significant concern.”

This device, which can be worn like a wrist-watch, uses finger based physiology and technology to facilitate testing for obstructive sleep apnoea.

It operates on Peripheral Arterial Tone (PAT) signal, which measures the arterial volume changes at the fingertip. These changes indicate the sympathetic nervous system activation.

The company additionally provides the EndoPAT system for testing endothelial dysfunction and to assess cardiovascular diseases risk.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact